Received Feb 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (NOVAVAX)) | NOVAVAX | 1 | — | IM / RA |
Acute Kidney Injury (AKI) unknown cause per nephrology consultation atnephrology on Feb 14, 2025. I am a physician and strongly suspect AKI as a vaccine adverse reaction because there were no other interventions, medication changes, changes in health or activity, NSAID use, recreational drug use or other precipitant. Nephro also diagnosed Chronic Renal Insufficiency as a result of AKI based on duration of renal injury.
Mild hypertension
VSD repair as a teen. Meniere's disease. Osteoporosis.
Lisinopril 5 mg daily, betahistine 8 mg twice daily, pioglitazine (for lichen planopilaris, NOT for diabetes) 15 mg daily
Allergic contact dermatitis to rivastigmine patch
Normal state of health, received Novavax COVID vax Thurs OCT 17, 2024. Following Monday, OCT 21, 2024, obtained creatinine for clearance for scheduled Reclast infusion. Creatinine returned elevated at 1.37. Patient was asymptomatic, normal activities. Baseline creatinines ~0.8X, most recent prior creatinine SEP 2023 0.88. Repeated 2 days later, OCT 23, creatinine 1.71. Not knowing direction this was heading, repeated OCT 24, value 1.27. Subsequent dates and values: Oct 28, 1.15; Nov 18, 1.22; Jan 14, *2025*, 1.11; Feb 12, 2025, 0.93. Recovery has been incomplete.